Back
Regeneron Pharmaceuticals Stock Predictions
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
45
REGN
Regeneron Pharmaceuticals
Last Price:
$713.28
Seasonality Move:
10.8%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.Regeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 31% based on the past 33 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 20 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.61%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $714.47. The Score for REGN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 31% based on the past 33 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
45
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 20 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.61%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
693.00
Prediction Charts
Market Cap:
78.5B
Price in USD:
714.47
Volume:
382.1K
Beta:
0.95
Technical Analysis
SMA50:
814.52
SMA100:
965.27
SMA200:
978.35
52-Wk Change:
-15.62%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 714.47 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 751.55 | 767.90 | 768.02 | 749.69 |
| Dec-6 | 768.64 | 778.00 | 778.12 | 765.16 |
| Dec-9 | 777.00 | 788.00 | 800.99 | 773.00 |
| Dec-10 | 784.10 | 778.50 | 791.49 | 762.70 |
| Dec-11 | 778.15 | 773.00 | 781.32 | 766.87 |
| Dec-12 | 773.12 | 740.97 | 778.73 | 740.46 |
| Dec-13 | 738.45 | 731.30 | 740.17 | 728.68 |
| Dec-16 | 730.52 | 724.87 | 739.39 | 722.23 |
| Dec-17 | 721.37 | 740.01 | 744.80 | 721.08 |
| Dec-18 | 735.21 | 714.62 | 745.00 | 712.30 |
| Dec-19 | 711.00 | 708.25 | 714.05 | 693.00 |
| Dec-20 | 710.20 | 701.85 | 717.61 | 700.83 |
| Dec-23 | 708.38 | 715.13 | 718.19 | 706.16 |
| Dec-24 | 712.30 | 714.47 | 720.00 | 706.15 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.58 per share, and a decrease next year of $0.14 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.